Navigation Links
Green tea flavonoid may prevent reinfection with hepatitis C virus following liver transplantation
Date:12/1/2011

German researchers have determined that epigallocatechin-3-gallate (EGCG)a flavonoid found in green teainhibits the hepatitis C virus (HCV) from entering liver cells. Study findings available in the December issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases, suggest that EGCG may offer an antiviral strategy to prevent HCV reinfection following liver transplantation.

HCV infection can lead to chronic hepatitis, cirrhosis, and hepatocellular carcinoma (HCC) or primary liver cancer. HCV is one of the most common causes of chronic liver disease and a primary indication for liver transplantation, affecting up to 170 million individuals worldwide according to estimates from the World Health Organization (WHO). Prior studies report that nearly 2% of the world population is infected with chronic HCV and up to 20% of the population in some countries.

While standard treatment with interferon with ribavirin and newer protease inhibitors may clear infection in some individuals, a substantial number of patients still may not respond to these therapies. For individuals receiving liver transplants due to complications from HCV, reinfection of the healthy donor liver remains a significant concern. Antiviral strategies that target HCV in its early stages are urgently needed to prevent graft reinfection and improve long-term outcomes for patients.

To address this critical issue, Dr. Sandra Ciesek and Dr. Eike Steinmann from the Hannover Medical School in Germany investigated the effect of the EGCG molecule, which is a major component of green tea, in preventing HCV from attaching to liver cells. "Green tea catechins such as EGCG and its derivatives epigallocatechin (EGC), epicatechingallate (ECG), and epicatechin (EC) have been shown to exhibit antiviral and anti-oncogenic properties," explains Dr. Ciesek. "Our study further explores the potential effect these flavonoids have in preventing HCV reinfection following liver transplantation."

Results showed that unlike its derivatives, EGCG inhibits entry of HCV into liver cells. The authors suggest that EGCG may impede HCV cell entry by acting on the host cell as the green tea catechin was not found to alter the density of virus particles. Pretreatment of cells with EGCG before HCV inoculation did not reduce the infection; however application during inoculation inhibited the rapid spread of the HCV. Lastly, researchers showed that EGCG inhibits viral attachmentthe initial step in the HCV infection process. "The green tea antioxidant EGCG inhibits HCV cell entry by blocking viral attachment and may offer a new approach to prevent HCV infection, particularly reinfection following liver transplantation." concludes Dr. Ciesek.


'/>"/>

Contact: Dawn Peters
healthnews@wiley.com
781-388-8408
Wiley-Blackwell
Source:Eurekalert

Related medicine news :

1. Public willing to pay more for greener urban spaces
2. Greenhouse Gas Emissions Could Fall as Population Ages
3. Radiologists: Going green with small, simple step
4. MDA, Walgreens collaborate to provide flu shots at more than 8,000 locations
5. Helping Maryland municipalities go green to save: New UMD initiative
6. Changing genetic red light to green holds promise for treating disease
7. Mechanism discovered for health benefit of green tea, new approach to autoimmune disease
8. Care for a spot of (green) tea? New NIST reference materials for popular diet supplement
9. Green environments essential for human health
10. Green tea and tai chi enhance bone health and reduce inflammation in postmenopausal women
11. Tungsten may not be the best shot for making green bullets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... (PRWEB) , ... December 06, 2016 , ... It can ... holiday presents for their four-legged family members as they do for their human friends ... pet parents’ desire to find the highest quality and most innovative pet products has ...
(Date:12/6/2016)... GA (PRWEB) , ... December 06, 2016 , ... ... and the impact of new federal healthcare regulations at the 7th annual Health ... Centre, Atlanta. , Andy Slavitt, acting administrator for the Centers for Medicare & ...
(Date:12/6/2016)... ... 2016 , ... The V Foundation for Cancer Research, a ... to Lose fundraising campaign. As the V Foundation’s boldest initiative to date, Not ... The campaign aims to raise $200 million by 2020 and strategically fund emerging, ...
(Date:12/6/2016)... ... 2016 , ... Just in time for the holiday season, the celebrated paleo ... for Honeyville’s new Organic Quinoa Flour product for sale at Costco stores throughout the ... , “I think it’s wonderful that a growing number of retailers such as ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... Friday, November 25th, when SevenPoint2 released the much-anticipated HydroFX for Water®. This ... label design. Featuring one of the world’s most powerful antioxidants, molecular hydrogen, ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... 5, 2016 Spain Glaucoma Surgery Devices Market ... "Spain Glaucoma Surgery Devices Market Outlook to 2022", provides ... market. The report provides value, in millions of US ... market segements - Canaloplasty Micro Catheters and Glaucoma Drainage ... distribution shares data for each of these market segements, ...
(Date:12/5/2016)... , Dec. 5, 2016  Cornerstone Pharmaceuticals, Inc., ... presented data from two Phase I trials evaluating ... the 58th annual meeting of the American Society ... California . The two datasets show encouraging ... myeloid leukemia (AML) and T-cell non-Hodgkin,s lymphoma (T-cell ...
(Date:12/5/2016)... YORK, Pa. , Dec. 5, 2016  Pennsylvania ... of Drug and Alcohol Programs Gary Tennis ... reversal drug, at Minnich,s Pharmacy in York ... standing order signed by Dr. Levine as a prescription ... "It,s important to remember that any ...
Breaking Medicine Technology: